Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Database
Language
Publication year range
1.
ACS Chem Biol ; 19(9): 2002-2011, 2024 Sep 20.
Article in English | MEDLINE | ID: mdl-39207862

ABSTRACT

Aminoglycosides are essential antibiotics used to treat severe infections caused mainly by Gram-negative bacteria. Gentamicin is an aminoglycoside and, despite its toxicity, is clinically used to treat several pulmonary and urinary infections. The commercial form of gentamicin is a mixture of five compounds with minor differences in the methylation of one of their aminosugars. In the case of two compounds, gentamicin C2 and C2a, the only difference is the stereochemistry of the methyl group attached to C-6'. GenB2 is the enzyme responsible for this epimerization and is one of the four PLP-dependent enzymes encoded by the gentamicin biosynthetic gene cluster. Herein, we have determined the structure of GenB2 in its holo form in complex with PMP and also in the ternary complex with gentamicin X2 and G418, two substrate analogues. Based on the structural analysis, we were able to identify the structural basis for the catalytic mechanism of this enzyme, which was also studied by site-directed mutagenesis. Unprecedently, GenB2 is a PLP-dependent enzyme from fold I, which is able to catalyze an epimerization but with a mechanism distinct from that of fold III PLP-dependent epimerases using a cysteine residue near the N-terminus. The substitution of this cysteine residue for serine or alanine completely abolished the epimerase function of the enzyme, confirming its involvement. This study not only contributes to the understanding of the enzymology of gentamicin biosynthesis but also provides valuable details for exploring the enzymatic production of new aminoglycoside derivatives.


Subject(s)
Gentamicins , Gentamicins/metabolism , Gentamicins/biosynthesis , Gentamicins/chemistry , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/biosynthesis , Anti-Bacterial Agents/metabolism , Racemases and Epimerases/metabolism , Racemases and Epimerases/genetics , Racemases and Epimerases/chemistry , Models, Molecular , Crystallography, X-Ray , Mutagenesis, Site-Directed , Bacterial Proteins/metabolism , Bacterial Proteins/chemistry , Bacterial Proteins/genetics
2.
Psychopharmacology (Berl) ; 237(8): 2499-2508, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32483676

ABSTRACT

Evidence indicates that neuroplasticity-based cognitive training can improve cognition in patients with schizophrenia, but the individual response to training varies greatly between subjects. Hence, there is a need to understand the neurological underpinnings of cognitive training to reveal predictors of treatment response. D-serine is a crucial modulator of neuroplasticity, and decreased levels of D-serine may contribute to deficits in neuroplasticity in schizophrenia. Interestingly, we observed that training mice to identify auditory oddballs increased extracellular levels of D-serine in the hippocampus during training. Serine racemase (Srr) is the only source of brain D-serine; thus, it is possible that Srr may mediate the response to training. To test this hypothesis, we trained mice that have a mutated version of Srr (SrrY269*/SrrY269*) and reduced levels of D-serine in the same auditory training. SrrY269*/SrrY269* mice showed decreased performance during auditory training (defined as the capacity to discriminate an oddball during a sequence of tones). Importantly, auditory training improved prepulse inhibition (PPI) in SrrY269*/SrrY269* but not in wild-type mice. Finally, D-serine (100 mg/kg i.p.) given 30 min before training sessions to SrrY269*/SrrY269* mice improved training performance, but it did not enhance PPI. Taken together, our results show that D-serine is involved in the response to neuroplasticity-based auditory training and that PPI deficits can be improved by auditory oddball training even in the presence of neuroplasticity deficits.


Subject(s)
Acoustic Stimulation/methods , Cognition/physiology , Prepulse Inhibition/physiology , Racemases and Epimerases/genetics , Racemases and Epimerases/metabolism , Animals , Cognition/drug effects , Hippocampus/drug effects , Hippocampus/metabolism , Male , Mice , Mice, Transgenic , Neuronal Plasticity/drug effects , Neuronal Plasticity/physiology , Prepulse Inhibition/drug effects , Schizophrenia/genetics , Schizophrenia/metabolism , Serine/pharmacology
3.
Asian Pac J Cancer Prev ; 15(21): 9335-9, 2014.
Article in English | MEDLINE | ID: mdl-25422221

ABSTRACT

BACKGROUND: To determine the frequency of primary circulating prostate cells (CPC) detection according to age and serum PSA levels in a cohort of men undergoing screening for prostate cancer and to determine the diagnostic yield in those men complying with the criteria for prostate biopsy. MATERIALS AND METHODS: A prospective study was carried out to analyze all men evaluated in a hospital prostate cancer screening program. Primary CPCs were obtained by differential gel centrifugation and detected using standard immunocytochemistry using anti-PSA, positive samples undergoing a second process with anti-P504S. A malignant primary CPC was defined as PSA+ P504S+, and a test positive if 1 cell/4ml was detected. The frequency of primary CPC detection was compared with age and serum PSA levels. Men with a PSA >4.0ng/ml and/or abnormal rectal examination underwent 12 core prostate biopsy, and the results were registered as cancer/no-cancer and compared with the presence/absence of primary CPCs to calculate the diagnostic yield. RESULTS: A total of 1,117 men participated; there was an association of primary CPC detection with increasing age and increasing serum PSA. Some 559 men underwent initial prostate biopsy of whom 207/559 (37.0%) were positive for primary CPCs and 183/559 (32.0%) had prostate cancer detected. The diagnostic yield of primary CPCs had a sensitivity of 88.5%, a specificity of 88.0%, and positive and negative predictive values of 78.3% and 94.9%, respectively. CONCLUSIONS: The use of primary CPCs for testing is recommended, since its high negative predictive value could be used to avoid prostate biopsy in men with an elevated PSA and/or abnormal DRE. Men positive for primary CPCs should undergo prostate biopsy. It is a test that could be implemented in the routine immunocytochemical laboratory.


Subject(s)
Early Detection of Cancer/methods , Neoplastic Cells, Circulating/pathology , Prostatic Neoplasms/epidemiology , Prostatic Neoplasms/pathology , Racemases and Epimerases/metabolism , Age Factors , Aged , Biomarkers, Tumor/metabolism , Biopsy, Needle , Chi-Square Distribution , Chile , Cohort Studies , Confidence Intervals , Humans , Immunohistochemistry , Male , Middle Aged , Needs Assessment , Neoplasm Invasiveness/pathology , Neoplasm Staging , Neoplastic Cells, Circulating/metabolism , Pilot Projects , Prospective Studies , Prostate-Specific Antigen/blood , Prostatic Neoplasms/blood , Racemases and Epimerases/genetics , Risk Assessment , Sensitivity and Specificity , Statistics, Nonparametric
4.
Schizophr Res ; 124(1-3): 208-15, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20875727

ABSTRACT

BACKGROUND: The AMACR gene is located in the schizophrenia susceptibility locus on chromosome 5p13, previously identified in a large Puerto Rican pedigree of Spanish origin. The AMACR-encoded protein is an enzyme involved in the metabolism of branched-chain fatty and bile acids. The enzyme deficiency causes structural and functional brain changes, and disturbances in fatty acid and oxidative phosphorylation pathways observed in individuals with schizophrenia. Therefore, AMACR is both a positional and functional candidate gene for susceptibility to schizophrenia. METHODS: The study had a two-step design: we performed mutation analysis of the coding and flanking regions of AMACR in affected members of the pedigree, and tested the detected sequence variants for association with schizophrenia in a Puerto Rican case-control sample (n=383) of Spanish descent. RESULTS AND CONCLUSION: We identified three missense variants segregating with the disorder in the family, rs2278008, rs2287939 and rs10941112. Two of them, rs2278008 and rs2287939, demonstrated significant differences in genotype (P = 4 × 10-4, P = 4 × 10-4) and allele (P = 1 × 10-4, P = 9.5 × 10-5) frequencies in unrelated male patients compare to controls, with the odds ratios (OR) 2.24 (95% CI: 1.48-3.40) and 2.25 (95% CI: 1.49-3.38), respectively. The G-C-G haplotype of rs2278008-rs2287939-rs10941112 revealed the most significant association with schizophrenia (P = 4.25 × 10-6, OR = 2.96; 95% CI: 1.85-4.76) in male subjects. There were no statistically significant differences in genotype, allele, and haplotype frequencies between female schizophrenia subjects and controls. Our results suggest that AMACR may play a significant role in susceptibility to schizophrenia in male patients.


Subject(s)
Mutation, Missense , Polymorphism, Single Nucleotide , Racemases and Epimerases/genetics , Schizophrenia/genetics , 3' Flanking Region/genetics , 5' Flanking Region/genetics , Adult , Alleles , Case-Control Studies , DNA Mutational Analysis , Family/psychology , Female , Genetic Predisposition to Disease , Genotype , Haplotypes , Humans , Male , Middle Aged , Open Reading Frames/genetics , Pedigree , Polymerase Chain Reaction , Puerto Rico , Sex Factors , Siblings/psychology
5.
J Antimicrob Chemother ; 51(3): 557-64, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12615855

ABSTRACT

Enterococcus gallinarum BM4175 (a vancomycin-susceptible derivative of BM4174 obtained by insertional inactivation of vanC-1) was transformed with plasmid constructs pCA10 (containing the genes necessary for resistance, vanC-1-XYc-T), pJP1 (with a fragment lacking the DNA encoding the transmembrane region of VanT, -vanC-1-XYc-T((Delta))(2-322)-) and with plasmids containing fragments encoding either the transmembrane (mvanT(1-322)) or racemase (svanT(323-698)) domains of VanT under the control of a constitutive promoter. Accumulated peptidoglycan precursors were measured in all strains in the presence of L-Ser, D-Ser (50 mM) or in the absence of any growth supplement. Uptake of 0.1 mM L-[(14)C]serine was also determined in BM4174, BM4175 and BM4175/pCA10. Vancomycin resistance was restored in BM4175 transformed with pCA10(C-1-XYc-T), and the profile of peptidoglycan precursors was similar to wild-type E. gallinarum BM4174. Transformation of E. gallinarum BM4175 with plasmid pJP1(vanC-1-XYc-T((Delta))(2-322)) resulted in: (i) vancomycin MICs remaining within susceptible levels (< or =4 mg/L) in the absence of any growth supplement, but increasing to 8 mg/L when either L-Ser or D-Ser was added to the medium; and (ii) the relative amounts of accumulated UDP-MurNAc-pentapeptide[D-Ser] and tetrapeptide precursors decreasing substantially compared with BM4175/pCA10 and BM4174. The effect on the appearance of tetrapeptide appeared to be host dependent, since a substantial amount was present when the same plasmid construct pJP1(vanC-1-XYc-T((Delta))(2-322)) was electroporated into Enterococcus faecalis JH2-2. The uptake of L-[(14)C]Ser at 240 s was decreased by approximately 40% in BM4175 compared with BM4174. Plasmid pCA10(C-1-XY(C)-T) restored uptake of L-[(14)C]Ser at 180 and 240 s in BM4175. The results suggest that the transmembrane domain of VanT is likely to be involved in the transport of L-Ser, and that in its absence the resistance phenotype is compromised.


Subject(s)
Enterococcus faecalis/enzymology , Enterococcus/enzymology , Membrane Proteins/physiology , Racemases and Epimerases/chemistry , Racemases and Epimerases/physiology , Vancomycin Resistance , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Enterococcus/drug effects , Enterococcus/genetics , Enterococcus faecalis/drug effects , Enterococcus faecalis/genetics , Membrane Proteins/genetics , Protein Structure, Tertiary , Racemases and Epimerases/genetics , Vancomycin Resistance/genetics
6.
Proc Natl Acad Sci U S A ; 99(22): 14542-7, 2002 Oct 29.
Article in English | MEDLINE | ID: mdl-12393813

ABSTRACT

High levels of d-serine occur in the brain, challenging the notion that d-amino acids would not be present or play a role in mammals. d-serine levels in the brain are even higher than many l-amino acids, such as asparagine, valine, isoleucine, and tryptophan, among others. d-serine is synthesized by a serine racemase (SR) enzyme, which directly converts l- to d-serine. We now report that SR is a bifunctional enzyme, producing both d-serine and pyruvate in cultured cells and in vitro. Transfection of SR into HEK 293 cells elicits synthesis of d-serine and augmented release of pyruvate to culture media. We identified substances present in HEK 293 and astrocyte cell extracts that strongly stimulate d-serine production by SR and elicit production of pyruvate. Experiments with recombinant enzyme reveal that Mg(2+) and ATP present in the cell extracts are physiological cofactors and increase 5- to 10-fold the rates of racemization and production of pyruvate. As much as three molecules of pyruvate are synthesized for each molecule of d-serine produced by SR. This finding constitutes a previously undescribed mechanism underlying d-amino acid synthesis in mammals, different from classical amino acid racemases present in bacteria. Our data link the production of d-serine to the energy metabolism, with implications for the metabolic and transmitter crosstalk between glia and neurons.


Subject(s)
Adenosine Triphosphate/metabolism , Magnesium/metabolism , Racemases and Epimerases/metabolism , Receptors, N-Methyl-D-Aspartate/agonists , Serine/biosynthesis , Adenosine Diphosphate/pharmacology , Adenosine Monophosphate/pharmacology , Adenosine Triphosphate/pharmacology , Animals , Cell Line , Humans , Ligands , Mice , Pyruvic Acid/metabolism , Racemases and Epimerases/genetics , Racemases and Epimerases/isolation & purification , Racemases and Epimerases/physiology
7.
Proc Natl Acad Sci U S A ; 98(9): 5294-9, 2001 Apr 24.
Article in English | MEDLINE | ID: mdl-11309496

ABSTRACT

Serine racemase is a brain-enriched enzyme that synthesizes d-serine, an endogenous modulator of the glycine site of N-methyl-d-aspartate (NMDA) receptors. We now report that serine racemase catalyzes an elimination reaction toward a nonphysiological substrate that provides a powerful tool to study its neurobiological role and will be useful to develop selective enzyme inhibitors. Serine racemase catalyzes robust elimination of l-serine O-sulfate that is 500 times faster than the physiological racemization reaction, generating sulfate, ammonia, and pyruvate. This reaction provides the most simple and sensitive assay to detect the enzyme activity so far. We establish stable cell lines expressing serine racemase and show that serine racemase can also be converted into a powerful eliminase in cultured cells, while the racemization of l-serine is inhibited. Likewise, l-serine O-sulfate inhibits the synthesis of d-serine in primary astrocyte cultures. We conclude that the synthetic compound l-serine O-sulfate is a better substrate than l-serine as well as an inhibitor of d-serine synthesis. Inhibition of serine racemase provides a new strategy to selectively decrease NMDA receptor coactivation and may be useful in conditions in which overstimulation of NMDA receptors plays a pathological role.


Subject(s)
Racemases and Epimerases/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Serine/analogs & derivatives , Serine/metabolism , Ammonia/metabolism , Animals , Astrocytes/cytology , Astrocytes/metabolism , Cell Line , Cells, Cultured , Humans , Hydrogen-Ion Concentration , Immunohistochemistry , Mice , Pyruvic Acid/chemistry , Pyruvic Acid/metabolism , Racemases and Epimerases/antagonists & inhibitors , Racemases and Epimerases/genetics , Recombinant Fusion Proteins/antagonists & inhibitors , Recombinant Fusion Proteins/metabolism , Serine/biosynthesis , Serine/chemistry , Stereoisomerism , Substrate Specificity
8.
Gene ; 256(1-2): 183-8, 2000 Oct 03.
Article in English | MEDLINE | ID: mdl-11054547

ABSTRACT

High levels of D-serine are found in mammalian brain, where it is an endogenous agonist of the strichinine-insensitive site of N-methyl D-aspartate type of glutamate receptors. D-serine is enriched in protoplasmic astrocytes that occur in gray matter areas of the brain and was shown to be synthesized from L-serine. We now report cloning and expression of human serine racemase, an enzyme that catalyses the synthesis of D-serine from L-serine. The enzyme displays a high homology to the murine serine racemase. It contains a pyridoxal 5'-phosphate attachment sequence similar to bacterial biosynthetic threonine dehydratase. Northern-blot analysis show high levels of human serine racemase in areas known to contain large amounts of endogenous D-serine, such as hippocampus and corpus callosum. Robust synthesis of D-serine was detected in cells transfected with human serine racemase, demonstrating the conservation of D-amino acid metabolism in humans. Serine racemase may be a therapeutic target in psychiatric diseases as supplementation of D-serine greatly improves schizophrenia symptoms. We identify the human serine racemase genomic structure and show that the gene encompasses seven exons and localizes to chromosome 17q13.3. Identification of the intron-exon boundaries of the human serine racemase gene will be useful to search for mutations in neuropsychiatric disorders.


Subject(s)
Racemases and Epimerases/genetics , Amino Acid Sequence , Base Sequence , Blotting, Northern , Brain/enzymology , Cell Line , Cloning, Molecular , DNA, Complementary/chemistry , DNA, Complementary/genetics , Exons , Genes/genetics , Humans , Introns , Molecular Sequence Data , RNA, Messenger/genetics , RNA, Messenger/metabolism , Racemases and Epimerases/metabolism , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL